Theranexus (EPA:ALTHX) | Finanzwire

Basculer en Français

10593	Companies
224658	Keywords
153356	Articles
118824	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 04/28/2026 at 19:00, 1 month 19 days ago

THX Pharma Publishes Its 2025 Annual Results, Cash Position as of March 31, 2026, and Provides a Business Update
THX Pharma announces annual results, cash position, and strategic partnerships, including Biocodex agreement. Financial stability secured. Focus on clinical development and commercialization of TX01 and Batten-1

Strategic Partnership Financial Stability Neurological Diseases THX Pharma Biocodex
BRIEF

published on 03/25/2026 at 18:50, 2 months 23 days ago

Theranexus publishes its letter to shareholders

Shareholders Biopharmaceutical Neurology Theranexus Drugs
BRIEF

published on 03/25/2026 at 18:50, 2 months 23 days ago

THX Pharma Publishes Letter to Shareholders

Innovation Shareholders Licensing Agreements Neurological Diseases THX Pharma
PRESS RELEASE

published on 03/25/2026 at 18:45, 2 months 23 days ago

THX Pharma Announces the Publication of its Letter to Shareholders
THX Pharma (Theranexus) announces the publication of a letter to shareholders regarding its innovative treatments for rare neurological diseases. Company details and contact information included

Shareholders Biopharmaceutical Theranexus Neurological Diseases THX Pharma
BRIEF

published on 02/25/2026 at 18:05, 3 months 20 days ago

THX Pharma increases the resources of its liquidity contract

Liquidity Contract Euronext Growth Biopharmaceutical Financial Resources THX Pharma
BRIEF

published on 02/19/2026 at 18:05, 3 months 26 days ago

THX Pharma strengthens its financial position as of December 31, 2025

Treasury Partnership Batten-1 TX01 Biocodex
BRIEF

published on 02/19/2026 at 18:05, 3 months 26 days ago

THX Pharma Announces Strong Cash Position at Year-End

Cash Position THX Pharma Biocodex Agreement Batten-1 Program TX01 Development
PRESS RELEASE

published on 02/19/2026 at 18:00, 3 months 26 days ago

THX Pharma Reports Its Cash Position as of December 31, 2025
THX Pharma (Theranexus) announces cash position of €7.8 million as of Dec 31, 2025. Pro forma cash position reaches €21.7 million with incoming payment from Biocodex agreement. Company focused on rare neurological diseases treatments development

Cash Position Rare Neurological Diseases Therapeutic Solutions THX Pharma Biocodex Agreement
BRIEF

published on 02/12/2026 at 18:05, 4 months 5 days ago

THX Pharma Announces Webinar on Strategic Agreement with Biocodex

Webinar Batten-1 Strategic Agreement THX Pharma Biocodex
BRIEF

published on 02/12/2026 at 18:05, 4 months 5 days ago

THX Pharma and Biocodex conclude a major strategic agreement

Webinar Strategic Agreement THX Pharma Neurological Medications Biocodex

Accesswire

Published on 06/18/2026 at 00:00, 10 hours 36 minutes ago

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 11 hours 6 minutes ago

Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 11 hours 46 minutes ago

International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 12 hours 6 minutes ago

Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 17 hours 41 minutes ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 09:30, 1 hour 6 minutes ago

AATec to Present Data from Lead Candidate ATL-105 at World Bronchiectasis Conference 2026
Published on 06/18/2026 at 09:10, 1 hour 26 minutes ago

Lenzing Group highlights scalable, bio-based nonwovens solutions at leading global industry fairs
Published on 06/18/2026 at 09:05, 1 hour 31 minutes ago

Norwegian Water and Energy Authority selects ICEYE to deliver nationwide satellite monitoring capability
Published on 06/18/2026 at 09:00, 1 hour 36 minutes ago

Original-Research: Limes Schlosskliniken AG (von NuWays AG): BUY
Published on 06/18/2026 at 09:00, 1 hour 36 minutes ago

Original-Research: Flughafen Wien AG (von NuWays AG): BUY

Les Echos

Published on 06/18/2026 at 09:06, 1 hour 30 minutes ago

Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 2 hours 6 minutes ago

OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 3 hours 36 minutes ago

bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 16 hours 56 minutes ago

Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 1 day 1 hour ago

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home

View all LES ECHOS COMFI WIRE